- Markets Pull Back for Incoming Inflation Data: Stock Market Today
- Everything you need to know before sending money
- The July jobs numbers are due out Friday. Here’s what to expect
- Aptoide becomes the first rival app store to return to Google Play in the US
- ADNOC Gas awards $8.2 billion in contracts for Rich Gas Development
- Markets Edge Lower after Robust Movement Last Week
- What to Expect From the July CPI Report
- Is a 60/40 Portfolio Too Aggressive in Your Seventies?
Author: Money Mechanics
Stocks notched new record closing highs to start Fed week as market participants cheered encouraging U.S.-China trade headlines. A big rally in tech stocks ahead of this week’s onslaught of mega-cap earnings also helped start the week on a high note.At the close, the Dow Jones Industrial Average was up 0.7% at 47,544, the S&P 500 was 1.2% higher at 6,875, and the Nasdaq Composite had gained 1.9% to 23,637 – new record highs for all three indexes.Over the weekend, reports emerged that the U.S. and China have hashed out a framework for a trade deal. On Thursday, President Donald…
Key Takeaways The average retirement account balance for Americans in their 70s is $250,000, but the median falls below $100,000. Once required minimum distributions (RMDs) start at 73, have a plan for your taxes. You’ve spent decades building your retirement savings. Now comes the part where you make it last. In your 70s, the questions change. It’s no longer about how much you can save—it’s about how much you can safely spend without running out of money. The average American in their 70s has $250,000 saved, but half have less than $107,000. Whether you’re above or below that line, the…
Key Takeaways From breathtaking mountain vistas to shimmering lakes and vibrant festivals, each town featured here offers more than just low taxes—they present a unique local flavor and abundant opportunities for active, engaged living.Across these destinations, taxes are low or nonexistent across all the main categories— income, property, and sales—empowering retirees to extend their savings.None of the cities highlighted in this article tax Social Security or other forms of retirement income, so retirees who primarily depend on these benefits may owe significantly less than the estimates provided. When it comes to the best places to retire in the U.S., headlines…
Lexeo Therapeutics Inc. (NASDAQ:LXEO) is one of the hot stocks to buy with huge upside potential. On October 21, H.C. Wainwright lowered the firm’s price target on Lexeo Therapeutics to $13 from $15 and kept a Buy rating on the shares. The price cut was made as the firm pointed out the share dilution from the most recent equity raise. Earlier on October 17, Leerink analyst Mani Foroohar also lowered the firm’s price target on Lexeo Therapeutics to $18 from $20 with an Outperform rating on the shares. Leerink noted the company’s announcement of a secondary offering and a concurrent…
In-brief analysis October 27, 2025 The pace of capacity additions for U.S. biofuel production slowed in 2024, with production capacity increasing by a modest 3% from the start of 2024 to the start of 2025, according to our latest biofuels production capacity reports. A deceleration in production capacity in our category renewable diesel and other biofuels accounted for most of the slowdown in growth. Sustainable aviation fuel (SAF), renewable naphtha, and renewable propane make up virtually all of the other biofuels. Renewable diesel and other biofuels Renewable diesel and other biofuels production capacity increased just…
Fed policy decision, ‘Mag 7’ earnings, and Trump-Xi meeting will be in focus this week. Meta is expected to report solid earnings and guidance thanks to AI-driven momentum and an improving digital ad market. Starbucks’ stock is trading in a vulnerable range, with technical indicators pointing to potential downside if earnings disappoint. Looking for actionable trade ideas? Subscribe now to unlock access to InvestingPro’s AI-selected stock winners! The stock market ended higher on Friday, with the major indexes clinching fresh records as cool inflation data and upbeat corporate earnings lifted investor sentiment. Source: Investing.com For the week, the 30-stock rallied…
Coke beverages are displayed in a 7-eleven convenient store on July 17, 2025 in Austin, Texas. Brandon Bell | Getty ImagesAmid recession fears, a government shutdown and tariff uncertainty, consumers are increasingly diverging in their spending.Wealthier Americans are engaging their purchasing power, while lower-income Americans are starting to pull back — commonly described as a “K-shaped” economy. Friday’s consumer price index report shed more light on the pressures facing large swaths of the country.The CPI report, which measures price changes across a range of goods and services, was delayed due to the government shutdown, originally scheduled to be released nine…
Meta’s X competitor, Threads, is introducing a new “disappearing posts” feature that will allow the app’s over 400 million monthly users to share their thoughts and engage in conversations that are automatically archived after 24 hours. The option, dubbed “ghost posts,” launches on Monday for Threads users worldwide. Users will now be able to create a ghost post on mobile devices by toggling on the new “ghost” icon on the app’s compose screen. When the post is published, it appears in others’ timelines with a dotted conversation bubble around it to differentiate the post from other content. Other users on…
Key Takeaways Novartis is buying Avidity Biosciences in an all-cash deal valued at $12 billion to access Avidity’s experimental treatments for neuromuscular diseases.The purchase price of $72 per share is a 46.5% premium to Avidity’s closing price Friday.Avidity stock was up more than 40% in midday trading Monday, as were shares of Dyne Therapeutics, which is also developing RNA therapies for neuromuscular diseases. Shares of Avidity Biosciences (RNA) soared more than 40% Monday after Novartis (NVS) agreed to buy the U.S. biopharmaceutical firm for about $12 billion in cash to expand its RNA-based disease-fighting pipeline. The Swiss-based drugmaker said Avidity…
(Investing) – Oil prices steadied Monday as traders digested potential progress in U.S.-China trade talks, starting to discount the chances of an economically costly trade war between the world’s two largest economies. At 08:25 ET (12:25 GMT), for December fell 0.1% to $65.14 a barrel and rose 0.1% to $61.54 a barrel. U.S., China agree to framework trade deal The U.S. and China have agreed to a framework trade deal, which will be discussed when leaders Donald Trump and Xi Jinping meet later in the week, U.S. officials said over the weekend. Washington is expected to not make good on its threat of…
